In February 2022, Mitsubishi Corporation Life Sciences Limited , manufactures and distributes value-added products in various industries, announced that the United States Patent and Trademark Office had granted a patent to the company for a method for improving nonalcoholic fatty liver disease in patients in need for treatment, compromising the administration of a composition containing glutathione as its active ingredient
Glutathione Support (extracellular) These forms of glutathione delivery will help ones antioxidant status but they do not raise levels of glutathione inside the cells: Liposomal cream - for use in localized areas, such as an area of pain or inflammation (ex: over an inflamed joint or over the thyroid in the case of autoimmune Hashimotos hypothyroidism)
Each bottle provides 30 servings
Chromium: Rare but Possible Side Effects: occasion irregular heartbeats, sleep disturbances, headaches, mood changes, and allergic reactions
Laboratory animals were housed in PC cages in conventional laboratory conditions at the temperature of 2024C, relative humidity of 4070%, and noise level of 60 dB
